Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3800316
Max Phase: Preclinical
Molecular Formula: C40H58Cl2F4N9O13P
Molecular Weight: 1050.83
Molecule Type: Small molecule
Associated Items:
ID: ALA3800316
Max Phase: Preclinical
Molecular Formula: C40H58Cl2F4N9O13P
Molecular Weight: 1050.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)Nc1c(F)c(F)c(COP(N)(=O)N(CCCl)CCCl)c(F)c1F)C1CCCCC1
Standard InChI: InChI=1S/C40H58Cl2F4N9O13P/c1-20(49-39(65)26-16-22(57)17-55(26)28(59)8-5-9-29(60)61)36(62)51-25(18-56)38(64)52-34(21-6-3-2-4-7-21)40(66)50-24(10-11-27(47)58)37(63)53-35-32(45)30(43)23(31(44)33(35)46)19-68-69(48,67)54(14-12-41)15-13-42/h20-22,24-26,34,56-57H,2-19H2,1H3,(H2,47,58)(H2,48,67)(H,49,65)(H,50,66)(H,51,62)(H,52,64)(H,53,63)(H,60,61)/t20-,22+,24-,25-,26-,34-,69?/m0/s1
Standard InChI Key: XMNNKLMDHOBTCU-KRUYCESSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1050.83 | Molecular Weight (Monoisotopic): 1049.3205 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wu X, Hu L.. (2016) Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen., 24 (12): [PMID:27156193] [10.1016/j.bmc.2016.04.035] |
Source(1):